Mangrove Partners Biomarin Pharmaceutical Inc Transaction History
Mangrove Partners
- $769 Million
- Q3 2024
A detailed history of Mangrove Partners transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mangrove Partners holds 10,334 shares of BMRN stock, worth $664,062. This represents 0.09% of its overall portfolio holdings.
Number of Shares
10,334Holding current value
$664,062% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
636Shares Held
178MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.46 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.24 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.21 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$893 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$674 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...